Olivier Reinhard

Olivier Reinhard is an accomplished senior executive with extensive experience in business development and strategic management across the pharmaceutical and healthcare sectors. Currently serving as Senior Director of Business Development at Roche since August 2023, Olivier Reinhard leads global projects focused on partnering strategies and deal negotiations in therapeutic areas such as neurology, oncology, immunology, and cardiometabolic health. Prior roles include Head of Business Development for Emerging Markets at Abbott, where Olivier Reinhard oversaw a team of 50 representatives and was responsible for external growth strategies, and Vice President of Business Development at Sanofi, leading global activities for General Medicine and emerging markets. Olivier Reinhard's earlier experience at Merial involved managing M&A processes and strategic project management, while a foundational role as a Financial Analyst at UBS included participation in healthcare M&A projects. Olivier Reinhard holds an Executive Leadership Program degree from IMD, an EMIM in Business Administration from ESCP Business School, and a License in Applied Mathematics from Université Paris Dauphine - PSL.